Home/Treos Bio/Christopher C. Gallen, M.D., Ph.D.
CC

Christopher C. Gallen, M.D., Ph.D.

CEO or Senior Executive/Board Member

Treos Bio

Therapeutic Areas

Treos Bio Pipeline

DrugIndicationPhase
PolyPEPI1018Metastatic Colorectal Cancer (MSS subtype)Phase 2